PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Data Integrity Scandal Prompts FDA Probel

Validating Value Data: AI and Outcomes

Surfing the Wave: The Patient-Data Puzzle

Research & Development
Shifting Approaches from Traditional R&D to Platform
Bernhardt Zeiher, Chief Medical Officer of Astellas discusses how the company transitioned from a traditional R&D approach to a platform approach, the need for innovation models to change in pharma, and the impact academia has on drug development.
... /Read more/
Advertisement
Order-To-Cash Management Fundamentals to Increase Profitability and Reduce Risk
Wednesday, November 20, 2019 at 10am EST| 9am CST| 3pm GMT| 4pm CET
Register Now
Emerging Markets
Silent (R)evolution in Medical Affairs Through the Power of Partnerships and Collaborations
A look at how medical affairs is transitioning to a new, fundamental strategic role within pharma and ways it can step up to own this role, particularly within emerging markets.
... /Read more/
Advertisement
A Modern Approach to Global Growth & Compliance in Life Sciences: A Story of Digitalization at Boehringer Ingelheim
November 13, 2019 at 2pm EDT | 1pm CDT | 11am PDT
Register Now
Industry Trends
Tech Tour for the C-Suite: Pharma’s Digital Future
Amid new findings on today’s C-suite approach to digital transformation, experts explore the intersection of data and technology and the areas that must evolve to meet the digital health demands of tomorrow.
... /Read more/
Advertisement
Launching Medical Devices in the Japanese Market
How to navigate regulatory and reimbursement approval

Thursday, October 31, 2019 at 11am EDT
Register Now
Advertisement
Japan Oncology Market – Best in Class Practices for Advancing Patient Outcomes
Tuesday, October 15, 2019 at 5pm JST
On Demand
Calendar
/ 5th Annual Bio/Pharmaceutical Product Launch Summit — 10/28-10/29 /
 
/ GTN 2019 — 11/12-11/14 /
 
/ 6th Annual Global Compliance Congress — 11/13-11/14 /
 
/ eyeforpharma Awards 2019 — 12/11 /
 
 
Cover Feature
Corey McCann: A PDT Pioneer
Corey McCann, president and CEO of Pear Therapeutics, discusses how the prescription digital therapeutics space has evolved in a decade from disruptive concept to an exciting, growing market.
... /Read more/
Advertisement
Japan Oncology Market – Best in Class Practices for Advancing Patient Outcomes
Tuesday, October 29, 2019 at 11am JST
Register Now
The Pharm Exec Podcast: Episode 42
Sponsored by Fingerpaint
Establishing a New Drug Therapy
Mark Glickman, Chief Commercial Officer of Esperion Therapeutics discusses the overall cholesterol-lowering space and how it’s planning to add a new therapeutic option for patients, what it means to establish a new therapy in a statin-dominated market, market research approaches, and more.
... /Read more/

We Want to Hear From YOU!

As the Pharm Exec podcast enters its 3rd year, we are asking that podcast listeners take a quick, five-minute survey where we glean more information about listeners—like what topics you’re interested in hearing about in the coming year. Please provide feedback before November 8th. We appreciate listeners taking the time to fill out our survey and help us provide a better, more comprehensive podcast.
Click here to take our survey

 
Advertisement
Launch Strategies: Trends and Challenges for Biotech Companies
Wednesday, October 23, 2019 at 10am EDT
Register Now
update my profile / advertise with us / print & digital subscribe / visit pharmexec.com